Common TitlePANNA (Raltegravir)
Official Title Study on Pharmacokinetics of Newly Developed ANtiretroviral Agents in HIV-infected pregNAnt Women (PANNA)
Phase Phase IV
ClinicalTrials.gov NCT00825929
Treatments
Raltegravir
Raltegravir
Tradename:IsentressOther Names:RALClass:Integrase Inhibitors (INSTI)Categories PharmacologyPregnancy/WomenGeneral Pharmacology
Funding
Non-IndustryRadboud University
References
- Blonk MI, Colbers AP, Hidalgo-Tenorio C, et al. Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy. Clin Infect Dis. 2015;61:809-16.